Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROTALIX BIOTHERAPEUTICS INC Financial Overview

  • Income Statement: PLX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit -1.30 M -759,000.00 -542,000.00 41.66%
    Net Income Before Extra Items/Preferred Div -22.41 M -22.48 M 67,000.00 -0.30%
    Operating Income -24.17 M -24.50 M 329,000.00 -1.36%
  • Cash Flow: PLX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -51,000.00 58.57 M -58.62 M 114,935.29%
    Net Cash Flow - Investing 3.70 M 2.44 M 1.26 M 34.13%
    Net Cash Flow/Operating Activities -16.02 M -10.45 M -5.57 M 34.75%
  • Balance Sheet: PLX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 50.81 M 68.14 M -17.33 M -34.10%
    Total Liabilities 6.46 M 4.45 M 2.01 M 31.13%
    Shareholders Equity 44.35 M 63.68 M -19.34 M -43.61%
  • Key Ratios / Statistics: PLX

    • Valuation

      Price/Earnings (TTM) -6.13
      Price/Sales (TTM) 532.71
      Price/Book (MRQ) 9.89
      Price/Cash Flow (TTM) -46.38
    • Profitability

      Gross Margin -130.67
      Operating Margin -3,859.33
      Profit Margin -3,830.67
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 7.82
      Current Ratio (MRQ) 5.00
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -42.12
      Return on Assets (TTM) -45.54
      Return on Investments (TTM) -41.50